Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Rheumatol Rep. 2006 Aug;8(4):303-11.

Wegener's granulomatosis: is biologic therapy useful?

Author information

  • 1Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

Abstract

Wegener's granulomatosis (WG) is a complex autoimmune disorder that has been transformed from a uniformly lethal process to a chronic disease with a relapsing-remitting course. In the setting of frequent relapses, the need to manage cumulative disease damage and drug toxicities has spurred the identification and development of new potent and directed therapies. Biologic agents, which offer the potential for remission-induction and drug-sparing approaches to treat WG, have been studied in several small, open-label clinical series and one large, randomized, placebo-controlled clinical trial. This article discusses the results of these trials and the potential of these biologic agents to treat WG.

PMID:
16839510
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk